QUANTERIX
Quanterix Corporation is developing a novel platform for single-molecule analysis that will bring an unprecedented level of sensitivity, precision, and assay robustness to clinical diagnostics, drug development, and life science research. Their unique approach permits rapid quantification and analysis of individual proteins and small molecules within complex biological samples, enabling us to address a variety of unmet medical needs. The company’s ultra-sensitive detection solution, Simoa, ... has the potential to change the way in which healthcare is provided today by giving researchers the ability to closely examine the role of biomarkers in the continuum of health to disease. Quanterix’s technology is designed to enable much earlier disease detection, better prognosis, and precise treatment methods to improve the quality of life and longevity of the population for generations to come.
QUANTERIX
Industry:
Biotechnology Health Care Health Diagnostics Life Science Pharmaceutical
Founded:
2007-01-01
Address:
Billerica, Massachusetts, United States
Country:
United States
Website Url:
http://www.quanterix.com
Total Employee:
251+
Status:
Active
Contact:
617-301-9400
Email Addresses:
[email protected]
Total Funding:
533.3 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress Google Universal Analytics
Similar Organizations
Advanced Cell Diagnostics
Advanced Cell Diagnostics is a molecular pathology company developing cell- and tissue-based diagnostic tests for personalized medicine.
Arcellx
Arcellx is a clinical-stage biotechnology company that provides patients with immune cell therapies.
Axcella
Axcella is a biotechnology company that treats diseases using endogenous metabolic modulators.
Quantum SI
Quantum SI offers Next Generation Protein Sequencing that makes diagnostics digital.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2019-06-26 | UmanDiagnostics | UmanDiagnostics acquired by Quanterix | 22.5 M USD |
Investors List
Alzheimer's Drug Discovery Foundation
Alzheimer's Drug Discovery Foundation investment in Grant - Quanterix
T. Rowe Price
T. Rowe Price investment in Series D - Quanterix
Hercules Capital
Hercules Capital investment in Series D - Quanterix
ARCH Venture Partners
ARCH Venture Partners investment in Series D - Quanterix
ARCH Overage Fund
ARCH Overage Fund investment in Series D - Quanterix
Tufts University
Tufts University investment in Series D - Quanterix
Bain Capital Ventures
Bain Capital Ventures investment in Series D - Quanterix
Cormorant Asset Management
Cormorant Asset Management investment in Series D - Quanterix
Trinitas Capital
Trinitas Capital investment in Series D - Quanterix
bioMerieux
bioMerieux investment in Series C - Quanterix
Key Employee Changes
| Date | New article |
|---|---|
| 2020-11-19 | Quanterix appoints chief operating officer |
Official Site Inspections
http://www.quanterix.com Semrush global rank: 241.55 K Semrush visits lastest month: 291.99 K
- Host name: ec2-34-199-95-206.compute-1.amazonaws.com
- IP address: 34.199.95.206
- Location: Ashburn United States
- Latitude: 39.0481
- Longitude: -77.4728
- Metro Code: 511
- Timezone: America/New_York
- Postal: 20149
More informations about "Quanterix"
Meet the Team - Quanterix
In addition, you agree to receive information regarding Quanterix products and services. You will be able to unsubscribe at any time. [email protected] 617 301 9400 900 Middlesex TPKE …See details»
Ultra-Sensitive Biomarker Detection | Quanterix
In addition, you agree to receive information regarding Quanterix products and services. You will be able to unsubscribe at any time. [email protected] 617 301 9400 900 Middlesex TPKE …See details»
Quanterix - Crunchbase Company Profile & Funding
Organization. Quanterix . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. About. Quanterix is a …See details»
Investor Relations | Quanterix
Apr 29, 2025 Quanterix is a company that is digitizing biomarker analysis with the goal of advancing the science of precision health. Our digital health solution, Simoa, has the potential to change the way in which healthcare is provided …See details»
Quanterix Corporation - AnnualReports.com
Quanterix is a company that’s digitizing biomarker analysis with the goal of advancing the science of precision health. The company’s digital health solution, Simoa®, has the potential to change the way in which healthcare is provided …See details»
Quanterix - Leadership Team - The Org
The Leadership Team at Quanterix is responsible for steering the company's strategic vision and operational efficiency in the field of precision health. Comprising senior executives from …See details»
Quanterix Corporation (QTRX): history, ownership, mission, how it …
Ever wondered how Quanterix Corporation (QTRX), a life sciences company with a market capitalization of $216.18 million, is revolutionizing precision health? Quanterix is digitizing …See details»
Quanterix Corp Company Profile - GlobalData
Quanterix Corp (Quanterix) is a life sciences company that develops and markets an ultra-sensitive digital immunoassay platform. It offers a biomarker detection system, antibodies and …See details»
Quanterix Company Profile - Office Locations, Competitors, …
Oct 29, 2024 Quanterix is a company that is digitizing biomarker analysis with the goal of advancing the science of precision health. The Company’s ultra-sensitive detection solution, …See details»
Quanterix - VentureRadar
Quanterix’ technology is designed to enable much earlier disease detection, better prognoses and enhanced treatment methods to improve the quality of life and longevity of the population for …See details»
Quanterix - Flagship Pioneering
Quanterix (NASDAQ: QTRX) is digitizing biomarker analysis with the goal of advancing the science of precision health. The company’s digital health solution, Simoa, has the potential to …See details»
Quanterix and Akoya Biosciences Announce Amended Merger …
Apr 29, 2025 Quanterix Files Updated Investor Presentation Highlighting Compelling Benefits of Combination. BILLERICA, Mass. and MARLBOROUGH, Mass. – April 29, 2025 – Quanterix …See details»
Quanterix - Overview, News & Similar companies | ZoomInfo.com
Quanterix to Participate at the Scotiabank Healthcare 1x1 Day BILLERICA, Mass.--(BUSINESS WIRE)--Quanterix Corporation (NASDAQ: QTRX), a company fueling scientific discovery …See details»
Quanterix and Akoya Biosciences Announce Amended Merger …
Apr 29, 2025 Quanterix shareholders will own approximately 84% of the combined company and Akoya shareholders will own approximately 16%. Masoud Toloue, PhD, Chief Executive …See details»
Quanterix - 2025 Company Profile, Funding & Competitors - Tracxn
Apr 29, 2025 Quanterix is a public company based in Cambridge (United States), founded in 2007. It operates as a Developer of assay kits for ultra-sensitive biomarker detection. …See details»
Careers - Quanterix
Quanterix is committed to our Employee’s health and well-being; we support our employees, and their families, in all of life’s moments. In addition to providing access to medical, dental and …See details»
A Brief History of Quanterix – CanvasBusinessModel.com
Dec 19, 2024 Founding and Origins of Quanterix. Quanterix was founded in 2007 by David Walt, a renowned scientist and professor at Tufts University, along with a team of experts in the field …See details»
Quanterix (QTRX) Earnings Date and Reports 2025 - MarketBeat
2 days ago Quanterix posted Q4 2024 earnings on March 17, 2025, reporting an EPS of -$0.30, which missed the consensus estimate of -$0.27 by $0.03. Quarterly revenue was reported to …See details»
Quanterix To Report First Quarter 2025 Financial Results on May …
BILLERICA, Mass. – May 2, 2025 – Quanterix Corporation (NASDAQ: QTRX), a company fueling scientific discovery through ultrasensitive biomarker detection, today announced that it will …See details»
Quanterix Q1 Earnings Preview - Seeking Alpha
1 day ago Quanterix (QTRX) is scheduled to announce Q1 earnings results on Monday, May 12th, after market close. The consensus EPS Estimate is -$0.43 (-65.4% Y/Y) and theSee details»